Palantir Stock Falls to $116 as Record Growth Meets Valuation Reset

Palantir shares hovered near $116, close to a 52-week low, even after the company posted record revenue growth and strong margins. The selloff highlights how rapidly market sentiment can punish richly valued AI stocks.

Palantir stock entered the third quarter near $116, leaving the shares down about 36% year to date and roughly 46% below their 52-week high of $207.52. The decline has been severe enough to push the stock close to its 52-week low of $106.37 despite some of the strongest operating results in the company’s history.

The tension is clear: Palantir Technologies has delivered exceptional growth, expanding margins and a swelling commercial backlog, yet investors have sharply repriced the stock. For the market, the central issue is not whether the business is growing, but whether the valuation still leaves enough room for error.

That disconnect has turned Palantir into a key test case for the 2026 AI trade. Investors are weighing elite software fundamentals against the risks of multiple compression in a market that has become less willing to pay peak prices for even the fastest-growing names.

Key Facts

  • Palantir stock traded near $116, about 44% below its December 2025 peak and roughly 46% below its 52-week high of $207.52.
  • The shares were down around 12% over one week, nearly 25% over one month, and about 36% year to date from a starting level near $178.
  • First-quarter 2026 revenue rose 84.7% year over year to $1.632 billion, marking the company’s highest growth rate to date.
  • GAAP operating income reached $754 million, equal to a 46% operating margin.
  • Palantir’s forward valuation stood near 77 times earnings, with a trailing P/E around 127 and a U.S. commercial backlog approaching $4.92 billion.

Palantir Stock

Palantir’s share decline is notable because it has not been driven by collapsing demand or weakening profitability. On the contrary, the company has reported accelerating revenue, high margins, and full-year guidance of $7.65 billion to $7.66 billion, implying roughly 71% annual growth. In most market environments, those numbers would be enough to support a rising share price.

Instead, the market has focused on valuation. At its late-2025 peak, Palantir had become one of the most expensive AI-linked equities, priced for near-flawless execution. Once investors began rotating away from richly valued AI winners in 2026, Palantir became especially vulnerable. A stock carrying a forward multiple near 77 and a trailing P/E around 127 offers little cushion if sentiment cools, even when the business continues to outperform.

That matters for a broad set of investors. Growth-oriented shareholders are confronting the reality that strong fundamentals do not always protect a high-multiple stock in a repricing cycle. More conservative investors, meanwhile, are asking whether the pullback has created a more reasonable entry point or whether the reset is still incomplete. With a beta near 1.5, Palantir remains more volatile than the broader market, amplifying both upside and downside.

Palantir’s 2026 selloff is a reminder that record growth can still be overshadowed when a stock is priced for perfection.

Why the valuation debate is so intense

Palantir’s bull case remains rooted in unusual operating strength. The company’s combination of 84.7% revenue growth and a 46% operating margin produces a Rule of 40 score near 145%, a level that places it in rare company among large-scale technology businesses. That metric is often used to evaluate software companies by combining growth and profitability into a single benchmark, with 40% typically viewed as strong.

Yet even exceptional metrics do not guarantee support for an extreme multiple. The market’s concern is straightforward: if growth slows from current levels, or if margins fail to keep expanding, the valuation could compress further. In other words, Palantir may be a better business than ever, but the stock can still decline if the market decides the premium remains too rich.

Implications for Investors

For investors, Palantir now sits at the intersection of opportunity and valuation risk. The opportunity lies in the company’s position within enterprise and government AI, where adoption continues to accelerate. Its U.S. commercial backlog, approaching $4.92 billion, suggests demand remains strong, while government and defense contracts provide a more durable revenue foundation. If management sustains its current growth trajectory, the company may gradually grow into a larger portion of its valuation.

The risk is that the stock is still not conventionally cheap. Even after a steep decline, a forward multiple near 77 means expectations remain elevated. Any disappointment in quarterly bookings, backlog conversion, margin expansion, or full-year guidance could trigger another leg down. Investors should watch the next earnings report closely for signs that commercial momentum, especially in AI platform adoption, remains intact.

Portfolio positioning matters here. Investors with a high tolerance for volatility may see Palantir as a long-term AI compounder undergoing a painful but rational reset. Others may prefer to wait for either a clearer technical base or further multiple compression before increasing exposure. For diversified portfolios, the stock’s high beta means position sizing is especially important.

The next phase for Palantir will depend less on whether the business can grow and more on what valuation the market is willing to assign that growth. If earnings continue to rise and the multiple stabilizes, the stock could rebuild. If investors keep demanding a lower price for AI growth, volatility is likely to remain the defining feature.

Ultima Markets